BiF-4 Insights – Deborah Brooks – Michael J. Fox Foundation

We want to de-risk ideas and help move them towards being taken into clinical trials.

We sometimes add money to company investments in order to make Phase 1 trials more robust than originally planned:

  • $4 million VC-funded trial, we incremented by $750k to fund neuro-imaging and extra doctor visit
    • In order to get more data out of the trial

We are almost filling the role of an early stage investor (in some cases).

Giving foundation money to drug companies must be a challenge for people giving money to the foundation to take, but we are pushing the envelope in order to do whatever we can to accelerate the finding of a cure.

For more information on the talk, go here.

Posted in

Braden Kelley

Braden Kelley is a Design Thinking, Innovation and Transformation Consultant, a popular innovation speaker and workshop leader, and helps companies plan organizational changes that are more human and less overwhelming. He is the author of Charting Change from Palgrave Macmillan and Stoking Your Innovation Bonfire from John Wiley & Sons. Braden has been advising companies since 1996, while living and working in England, Germany, and the United States. Braden earned his MBA from top-rated London Business School. Follow him on Twitter and Linkedin.

NEVER MISS ANOTHER NEWSLETTER!

Categories

LATEST BLOGS

Our Annual Trends Report: Boosting the Possibilities for 2021

By Shawn Nason | February 25, 2021

  I still remember the day we got the email telling us that the in-person version of the 2021 Consumer…

Read More

Controlling the controllables

By Janet Sernack | February 22, 2021

A recent article by McKinsey and Co “COVID-19: Implications for business”  describes a paradoxical dilemma for managers: the need to process both the…

Read More

Leave a Comment